IL6 and glioblastoma: Moreover, since STAT3 signaling is a downstream effector of interleukin-6 (IL-6), blocking IL-6R alpha or IL-6 expression in GSCs by shRNAs suppresses tumor sphere formation capacity and increases the survival of mice bearing intracranial glioblastoma xenografts [46].